Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, currently available in the UK only as an injectable formulation (Mounjaro) for type 2 diabetes management
It is the speed and composition of the weight loss
These differences in structure affect how each compound interacts with the target receptors and maintains activity in research
And their board got overhauled a few days ago
Laboratory testing (complete blood count, erythrocyte sedimentation rate, C-reactive protein, thyroid function) with normal results excludes inflammatory, autoimmune, or endocrine disorders, but doesnt define the underlying diagnosis when its FM
MACE, as a composite endpoint, was defined as the first occurrence of unstable angina, myocardial infarction or revascularisation (including PCI or coronary artery bypass graft) [19, 20]